Winton Group LTD Entrada Therapeutics, Inc. Transaction History
Winton Group LTD
- $1.35 Billion
- Q1 2024
A detailed history of Winton Group LTD transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Winton Group LTD holds 32,555 shares of TRDA stock, worth $461,955. This represents 0.03% of its overall portfolio holdings.
Number of Shares
32,555Holding current value
$461,955% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding TRDA
# of Institutions
76Shares Held
25.7MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$69 Million0.87% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$62.8 Million25.58% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$62.6 Million22.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.75MShares$39.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.49MShares$21.1 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $445M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...